M
MDGL
Madrigal Pharmac
517.26
+3.67+0.71%After Hours: 517.26 0.00 0.00%16:56 05/22 EDT
OPEN/PREV CLOSE513.00/513.59
TODAY RANGE507.06-520.89
VOL160.81K
MARKET CAP11.93B
52 WEEK RANGE265.00-615.00
AVG VOL (3M)321.78K
% TURNOVER0.70%
TURNOVER--
P/E (TTM)-37.9457
% RANGE2.69%
EPS(TTM)-13.6316
P/E(FORWARD)-78.8506
P/B21.93
BVPS23.59
DIVIDEND--
P/S12.33
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP11.24B
SHARES OUTSTANDING23.06M
NEXT EARNINGS08/03-08/07
FREE FLOAT21.73M
LOT SIZE1
EX-DATE07/25/2016
News
Press Releases
Financial Reports
Profile
TipRanks·3d ago
Madrigal’s Rezdiffra Drives Blockbuster Growth Amid Costs
TipRanks·4d ago
Top Madrigal Pharma Executive Makes Eye-Catching Stock Move
Simply Wall St·6d ago
What Madrigal Pharmaceuticals (MDGL)'s Wider Q1 Losses and Rezdiffra Revenue Momentum Mean For Shareholders
Seeking Alpha·05/15 21:44
John Paulson’s fund initiates Amicus Therapeutics position, dumps SOLS among Q1 moves
TipRanks·05/15 21:21
Paulson takes new stake in Amicus, cuts position in Madrigal Pharma
Seeking Alpha·05/14 18:19
Sagimet Biosciences: Making The Bull Case For Differentiated Denifanstat
Reuters·05/13 17:36
BUZZ-U.S. STOCKS ON THE MOVE -Fervo, Sensata Technologies, Akamai
Reuters·05/13 16:10
BUZZ-U.S. STOCKS ON THE MOVE-Chipmakers, Dynatrace, Alibaba
Dow Jones·05/13 15:15
Madrigal Pharmaceuticals Is Maintained at Buy by Truist Securities
TipRanks·05/13 13:52
Madrigal Pharmaceuticals price target raised to $709 from $640 at Truist